If you look up any research peptide in a scientific database, you will find a string of letters that looks something like this: GEPPRGKRPKDDDDPMLGSQ. That is not a typo or a placeholder. It is a peptide sequence written in single-letter amino acid code, and it tells anyone fluent in that notation exactly which amino acids appear in the chain and in what order. Peptide sequences are the fundamental language of peptide science. They encode everything important about a compound’s identity, and understanding how they work makes the rest of the field considerably easier to follow. Here is how sequences are structured, how they are written, and how they connect to the naming conventions researchers use.
Contents
The Amino Acid Alphabet: Single-Letter and Three-Letter Codes
Every peptide sequence is built from the same set of twenty standard amino acids, and each of those amino acids has been assigned both a three-letter abbreviation and a single-letter code. Both systems are in active use, and researchers switch between them depending on context and convenience.
Three-Letter Codes
The three-letter code is the older and more intuitive system. Glycine becomes Gly, alanine becomes Ala, serine becomes Ser, and so on. Most of the abbreviations are obvious once you know the amino acid names. A few are less predictable: tryptophan is Trp, cysteine is Cys, and phenylalanine is Phe. Three-letter codes are commonly used in structural biology and in contexts where readability matters more than compactness, such as textbook diagrams or sequence annotations in research papers.
Single-Letter Codes
The single-letter code assigns one letter of the alphabet to each of the twenty standard amino acids. Some assignments are straightforward: alanine is A, glycine is G, leucine is L. Others are more arbitrary, assigned to letters that the obvious choice was already using. Asparagine is N, glutamine is Q, and lysine is K. When you see a string of single letters used to describe a peptide, each letter represents one amino acid in the chain. This compact notation is standard in database records, sequence databases, and computational biology, where handling long sequences efficiently matters more than visual intuition.
How Peptide Sequences Are Read: Directionality Matters
A peptide sequence is not symmetrical. Every peptide chain has two chemically distinct ends, and the convention for reading and writing sequences is standardized around those ends. Getting the direction right is not a minor point. Reversing a sequence produces a different compound.
The N-Terminus and C-Terminus
One end of every peptide chain is called the N-terminus, which carries a free amino group. The other end is the C-terminus, which carries a free carboxyl group. By universal convention, peptide sequences are always written from left to right starting at the N-terminus and ending at the C-terminus. So the sequence Gly-Ala-Ser means a peptide that starts with glycine at the N-terminus, followed by alanine, and ending with serine at the C-terminus. The reverse sequence, Ser-Ala-Gly, is a different compound with different chemical properties, even though it contains the same three amino acids.
Why Directionality Affects Biological Activity
The N-to-C directionality of a sequence is not just a naming convention. It reflects a real chemical asymmetry that affects how the peptide interacts with enzymes, receptors, and other molecular partners. Many biological receptors are highly sensitive to the orientation of the peptide sequences they bind. A reversed sequence may bind poorly or not at all, or may interact in an entirely different way. Researchers studying peptide biology pay close attention to sequence directionality for this reason, and modifications to the N- or C-terminus of a peptide are a common strategy for altering its properties in controlled ways.
How Research Peptides Are Named
Beyond the sequence notation, research peptides acquire names through several different routes, and the same compound often ends up known by multiple names simultaneously. Understanding where those names come from helps clarify why CAS numbers and sequences are more reliable identifiers than names alone.
Systematic IUPAC Names
The International Union of Pure and Applied Chemistry provides a formal naming system for chemical compounds that generates a unique, unambiguous name for any molecule based on its structure. For peptides, the IUPAC name describes the full sequence in three-letter code using a standardized format. These names are technically precise and completely unambiguous, but they are also extremely long for anything beyond a tripeptide. The IUPAC name for BPC-157 runs to well over one hundred characters. In practice, nobody uses IUPAC names in conversation, but they appear in formal documentation and database records.
Common Names, Abbreviations, and Alphanumeric Designators
Most research peptides are known primarily by shorter names that emerged from the research groups that first described them or from the commercial context in which they were developed. BPC-157 stands for Body Protection Compound-157. TB-500 is derived from Thymosin Beta-4. CJC-1295 is an alphanumeric designator from a pharmaceutical development program. These names are convenient and widely used, but they are not systematic. Two different research groups might assign different names to the same compound, and the same abbreviation might occasionally refer to different compounds in different literature contexts. This is the practical reason why CAS numbers and sequence notation remain the most reliable ways to identify a peptide unambiguously.
Modified and Non-Standard Sequences in Peptide Research
Not all research peptides consist exclusively of the twenty standard amino acids arranged in a straightforward linear chain. A significant portion of peptide research involves compounds with modifications that extend beyond the basic sequence notation.
Researchers frequently introduce modifications to improve a peptide’s stability, alter its receptor binding properties, or extend its effective duration in biological assays. Common modifications include D-amino acids (the mirror-image versions of the standard L-amino acids), N-methylation of specific residues, cyclization of the chain to form a ring structure, and the addition of chemical groups to the N- or C-terminus. These modifications are indicated in sequence notation using bracketed annotations or specialized symbols that make clear where the modification occurs and what it involves. A sequence written as Ac-GEPPRGKRP-NH2, for example, indicates a peptide with an acetyl group on the N-terminus and an amide group on the C-terminus, both of which affect its stability and behavior compared to the unmodified sequence.
Frequently Asked Questions About Peptide Sequences and Naming
Sequence notation and peptide naming generate consistent questions among researchers and readers who are building their familiarity with the conventions of peptide science.
- What is a peptide sequence and how is it written?
- A peptide sequence is the precise ordered list of amino acids in a peptide chain, written from the N-terminus on the left to the C-terminus on the right. It can be written using three-letter amino acid codes separated by hyphens, such as Gly-Ala-Ser, or in compact single-letter notation such as GAS. Each letter or abbreviation represents one amino acid in the chain, and the order is chemically significant.
- Why does the direction of a peptide sequence matter?
- Peptide chains have two chemically distinct ends, the N-terminus and the C-terminus, and the two ends are not interchangeable. Reading or writing a sequence in the wrong direction describes a different compound. The convention is always to write sequences from N-terminus to C-terminus, left to right. Biological receptors and enzymes are often sensitive to this directionality, so reversing a sequence typically produces a compound with very different biological properties.
- Why do research peptides have so many different names?
- Peptide names arise from multiple sources: formal IUPAC nomenclature based on chemical structure, common names assigned by the research groups that first characterized them, alphanumeric designators from pharmaceutical development programs, and commercial trade names. Because naming is not fully standardized across these different contexts, the same compound often accumulates multiple names over time. CAS numbers and sequence notation are more reliable for unambiguous identification.
- What are D-amino acids and why do researchers use them in synthetic peptides?
- D-amino acids are the mirror-image forms of the standard L-amino acids found in natural proteins. Incorporating D-amino acids into a synthetic peptide sequence can significantly increase the compound’s resistance to enzymatic degradation, because the proteases that break down natural peptides are typically specific to L-amino acid sequences. This makes D-amino acid substitutions a useful tool for researchers who want to study a peptide’s effects in biological systems over longer timeframes without rapid degradation.